Kolkata: Drug Trafficker Wanted For Smuggling 14,998 Cough Syrup Bottles Nabbed By NCB

Kolkata:  The Narcotics Control Bureau (NCB) Kolkata arrested a notorious drug trafficker with a history of gold smuggling wanted in a seizure of a huge quantity of bottles of Codeine Based Cough Syrups (CBCS), officials said on Saturday.

As per a release, in one of the most challenging anti-drug operations regarding interception of illicit trafficking of Codeine Based Cough Syrups (CBCS) destined to Bangladesh, NCB Kolkata has, on November 13, 2024 arrested an International drug trafficker namely Gautam Mondal from Kolkata who was wanted in a seizure of 14,998 bottles of GBCS (brand name Phensedyl) of NCB Kolkata.

NCB said that Gautam Mondal is a notorious drug trafficker with a history of Gold smuggling. “He has 3 known cases of DRI regarding smuggling of huge quantities of Gold worth Crores. He had also clutched his claws upon the illicit trafficking of CBCS routed through West Bengal and destined to Bangladesh. Gautam Mondal is a long-time wanted habitual offender in 3 known NDPS cases of STF West Bengal,” the NCB said.

The NCB further said that the seized CBCS in the case of NCB Kolkata were sourced from Uttar Pradesh and illegally diverted from legal channels.

“Gautam Mondal is hard core NDPS offender whose modus operandi is to work in several layers. He has trained several of his henchmen to work in pairs for a particular set of duties and keeps on changing them so as to avoid detection by drug law enforcement agencies,” NCB further added.

NCB said that Gautam’s arrest is a significant blow on the functioning of his whole drug trafficking organization which he was running from the top. “Investigation to identify and apprehend his aides is on. Joint Interrogation with DRI Kolkata and STF West Bengal will be done to dismantle his organized crime syndicate,” NCB added.

Related Posts

  • Pharma
  • March 20, 2025
  • 37 views
Patanjali’s study on Renogrit, that fights cancer drug-induced kidney damage, among 2024’s most notable research papers

A research paper published on Patanjali’s Renogrit, a formulation that is effective against cancer drug cisplatin’s damaging effect on kidneys, has been featured among the most notable research studies of 2024.…

  • Pharma
  • March 19, 2025
  • 122 views
Strides Pharma approves demerger from Arco Labs

Strides Pharma is set to demerge from Arco Labs, a global capability centre, the company said in its exchange filing on Wednesday. Board of Directors of Strides Pharma Science Limited (Strides) and Arco…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Patanjali’s study on Renogrit, that fights cancer drug-induced kidney damage, among 2024’s most notable research papers

Patanjali’s study on Renogrit, that fights cancer drug-induced kidney damage, among 2024’s most notable research papers

Strides Pharma approves demerger from Arco Labs

Strides Pharma approves demerger from Arco Labs

Milestone Pharma Expands Sale Agreement, Increases Offering

Milestone Pharma Expands Sale Agreement, Increases Offering

Novo Nordisk regains membership in UK pharma body

Novo Nordisk regains membership in UK pharma body

USV Joins Empagliflozin generic contest, launches its brand Xenia

USV Joins Empagliflozin generic contest, launches its brand Xenia

SMS Hospital revamps blood safety protocols after fatal transfusion error

SMS Hospital revamps blood safety protocols after fatal transfusion error